Peter Bronsert
Overview
Explore the profile of Peter Bronsert including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
148
Citations
3177
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Stockinger E, Luxenburger H, Bettinger D, Berlin C, Obwegs D, Sagar , et al.
Hepatol Commun
. 2025 Feb;
8(10).
PMID: 39992088
Background: Despite the rising prevalence of liver cirrhosis and HCC worldwide, reliable prognostic blood biomarkers are lacking. Melanoma cell adhesion molecule (MCAM) is a cell adhesion protein, and its cleavage...
2.
Braun L, Giesler S, Andrieux G, Riemer R, Talvard-Balland N, Duquesne S, et al.
Cancer Cell
. 2025 Feb;
43(2):269-291.e19.
PMID: 39933899
Immune-related adverse events (irAEs) in cancer patients receiving immune checkpoint inhibitors (ICIs) cause morbidity and necessitate cessation of treatment. Comparing irAE treatments, we find that anti-tumor immunity is preserved in...
3.
Hoeppner J, Brunner T, Schmoor C, Bronsert P, Kulemann B, Claus R, et al.
N Engl J Med
. 2025 Jan;
392(4):323-335.
PMID: 39842010
Background: The best multimodal approach for resectable locally advanced esophageal adenocarcinoma is unclear. An important question is whether perioperative chemotherapy is preferable to preoperative chemoradiotherapy. Methods: In this phase 3,...
4.
Waibel P, Glavynskyi I, Fechter T, Mix M, Kind F, Sigle A, et al.
Eur J Nucl Med Mol Imaging
. 2025 Jan;
PMID: 39821663
Purpose: Prostate-specific membrane-antigen positron emission tomography (PSMA PET) is a promising candidate for non-invasive characterization of prostate cancer (PCa). This study evaluated whether PET with tracers [Ga]Ga-PSMA-11 or [F]PSMA-1007 is...
5.
Malyi A, Bronsert P, Schilling O, Honselmann K, Bolm L, Szanyi S, et al.
HPB (Oxford)
. 2025 Jan;
27(3):393-401.
PMID: 39818518
Background: In pancreatic surgery Postoperative pancreatic fistula (POPF) represents the most dreaded complication, for which pancreatic texture is acknowledged as one of the strongest predictors. No consensual objective reference has...
6.
Kurowski K, Foll M, Werner T, Schilling O, Werner M, Fichtner-Feigl S, et al.
J Cancer
. 2025 Jan;
16(1):1-11.
PMID: 39744576
Intrahepatic cholangiocarcinoma (iCC) is a rare malignant liver tumor with limited therapeutic advancements. Despite its increasing global incidence knowledge of treatment options remains stagnant, leading to poor five-year patient survival...
7.
Kurowski K, Timme S, Foll M, Backhaus C, Holzner P, Bengsch B, et al.
Methods Protoc
. 2024 Dec;
7(6).
PMID: 39728616
Immunohistochemical (IHC) studies of formalin-fixed paraffin-embedded (FFPE) samples are a gold standard in oncology for tumor characterization, and the identification of prognostic and predictive markers. However, despite the abundance of...
8.
Dinh T, Rogg M, Cosenza-Contreras M, Li M, Zirngibl M, Pinter N, et al.
J Pathol
. 2024 Nov;
265(1):41-56.
PMID: 39582373
We present the proteomic profiling of 79 bladder cancers, including treatment-naïve non-muscle-invasive bladder cancer (NMIBC, n = 17), muscle-invasive bladder cancer (MIBC, n = 51), and neoadjuvant-treated MIBC (n = ...
9.
Lakkimsetty S, Weber A, Bemis K, Stehl V, Bronsert P, Foll M, et al.
Bioinformatics
. 2024 Oct;
40(11).
PMID: 39418178
Summary: Joint analysis of mass spectrometry images (MS images) and microscopy images of hematoxylin and eosin (H&E) stained tissues assists pathologists in characterizing the morphological structure of the tissues, and...
10.
Gentile G, Poggio T, Catalano A, Voutilainen M, Lahnalampi M, Andrade-Martinez M, et al.
Blood Adv
. 2024 Apr;
8(11):2846-2860.
PMID: 38598725
The t(1;19) translocation, encoding the oncogenic fusion protein E2A (TCF3)-PBX1, is involved in acute lymphoblastic leukemia (ALL) and associated with a pre-B-cell receptor (preBCR+) phenotype. Relapse in patients with E2A-PBX1+...